These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11591709

  • 21. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S, Capra V, Mezzetti M, Nicosia S, Rovati GE.
    Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
    [Abstract] [Full Text] [Related]

  • 22. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L, Norel X, Bäck M, Gascard JP, Dahlén SE, Brink C.
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [Abstract] [Full Text] [Related]

  • 23. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
    Maekawa A, Balestrieri B, Austen KF, Kanaoka Y.
    Proc Natl Acad Sci U S A; 2009 Jul 14; 106(28):11685-90. PubMed ID: 19561298
    [Abstract] [Full Text] [Related]

  • 24. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M, Lewis K, Vale W.
    Mol Endocrinol; 2005 Feb 14; 19(2):441-58. PubMed ID: 15514029
    [Abstract] [Full Text] [Related]

  • 25. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
    Gronert K, Martinsson-Niskanen T, Ravasi S, Chiang N, Serhan CN.
    Am J Pathol; 2001 Jan 14; 158(1):3-9. PubMed ID: 11141472
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses.
    Maekawa A, Austen KF, Kanaoka Y.
    J Biol Chem; 2002 Jun 07; 277(23):20820-4. PubMed ID: 11932261
    [Abstract] [Full Text] [Related]

  • 28. Transgenic smooth muscle expression of the human CysLT1 receptor induces enhanced responsiveness of murine airways to leukotriene D4.
    Yang G, Haczku A, Chen H, Martin V, Galczenski H, Tomer Y, Van Besien CR, Evans JF, Panettieri RA, Funk CD.
    Am J Physiol Lung Cell Mol Physiol; 2004 May 07; 286(5):L992-1001. PubMed ID: 15064240
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
    Wang ML, Huang XJ, Fang SH, Yuan YM, Zhang WP, Lu YB, Ding Q, Wei EQ.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):399-404. PubMed ID: 17010308
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
    Ni NC, Yan D, Ballantyne LL, Barajas-Espinosa A, St Amand T, Pratt DA, Funk CD.
    J Pharmacol Exp Ther; 2011 Dec 17; 339(3):768-78. PubMed ID: 21903747
    [Abstract] [Full Text] [Related]

  • 33. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
    Kamohara M, Takasaki J, Matsumoto M, Matsumoto Si, Saito T, Soga T, Matsushime H, Furuichi K.
    Biochem Biophys Res Commun; 2001 Oct 12; 287(5):1088-92. PubMed ID: 11587533
    [Abstract] [Full Text] [Related]

  • 34. A functional study on CysLT(1) receptors in human eosinophils.
    Ohshima N, Nagase H, Koshino T, Miyamasu M, Yamaguchi M, Hirai K, Yamamoto K, Fujisawa T, Nakagawa N, Kishikawa K, Morita Y.
    Int Arch Allergy Immunol; 2002 Sep 12; 129(1):67-75. PubMed ID: 12373000
    [Abstract] [Full Text] [Related]

  • 35. Expression of functional cysteinyl leukotriene receptors by human basophils.
    Gauvreau GM, Plitt JR, Baatjes A, MacGlashan DW.
    J Allergy Clin Immunol; 2005 Jul 12; 116(1):80-7. PubMed ID: 15990778
    [Abstract] [Full Text] [Related]

  • 36. A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate.
    Thompson MD, Capra V, Takasaki J, Maresca G, Rovati GE, Slutsky AS, Lilly C, Zamel N, McIntyre Burnham W, Cole DE, Siminovitch KA.
    Pharmacogenet Genomics; 2007 Jul 12; 17(7):539-49. PubMed ID: 17558309
    [Abstract] [Full Text] [Related]

  • 37. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.
    Austen KF, Maekawa A, Kanaoka Y, Boyce JA.
    J Allergy Clin Immunol; 2009 Sep 12; 124(3):406-14; quiz 415-6. PubMed ID: 19647860
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM).
    Iwasaki T, Chin WW, Ko L.
    J Biol Chem; 2001 Sep 07; 276(36):33375-83. PubMed ID: 11443112
    [Abstract] [Full Text] [Related]

  • 40. Molecular and functional aspects of human cysteinyl leukotriene receptors.
    Capra V.
    Pharmacol Res; 2004 Jul 07; 50(1):1-11. PubMed ID: 15082024
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.